Bergen Bio ASA’s Axl kinase blocker bemcentinib in combination with MSD’s pembrolizumab has met the primary endpoint in a Phase II study in patients with non small cell lung cancer (NSCLC).
German researchers have designed a modified Sleeping Beauty transposase that can be used for non-viral, stable and efficient gene insertions for gene and CAR-T therapies.
https://european-biotechnology.com/wp-content/uploads/2024/04/Transposase.jpg425620Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-11-05 07:13:312019-11-05 07:13:31Transposase makes CAR-T production cheaper
https://european-biotechnology.com/wp-content/uploads/2024/04/2019_11_05_staphyllo_sw.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-11-05 06:21:182024-04-02 16:20:39New players to step into the AMR field
Renowned immunologist Iain McInnes has been appointed to the Scientific Advisory Boar of Oxford BioDynamics Plc, where he joins Karol Sikora, Jane Mellor and Lucien Peng-Jin Ooi.
Breast cancer might be detected up to five years before there are any clinical signs of it, using a blood test that identifies the body’s immune response to substances produced by tumour cells.
https://european-biotechnology.com/wp-content/uploads/2024/04/breast_cancer_NCI.jpg611600Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-11-04 06:58:282019-11-04 06:58:28Test detects breast cancer in earliest stage
BioEcho develops single-spin and 96-well kits for the isolation of DNA from different starting materials. In contrast to common bind-wash-elute procedures their proprietary EchoLUTION single-step technology avoids the use of inhibitory or harmful process reagents and does not require washing steps.
Synbio specialist Sherlock Biosciences and next-generation lateral flow testing expert Mologic Ltd have joined forces to develop a no-instrument rapid testing platform detecting virtually every infectious pathogen in low resource settings.
https://european-biotechnology.com/wp-content/uploads/2024/04/Mologic.jpg400740Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-11-01 08:49:442019-11-01 08:49:44Sherlock Bioscience and Mologic enter partnership
German researchers have shown that a protein protects against the development of liver fibrosis by shutting down inflammatory signalling in liver stellate cells of the liver.
https://european-biotechnology.com/wp-content/uploads/2024/04/bitbio_myocytes.jpg20912091Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-10-30 06:46:002019-10-30 06:46:00bit bio restarts with new management
Swiss biotech company BioVersys AG has received a €8m grant by US-based non-profit organisation CARB-X to develop novel anti-virulence antibiotics to treat severe bacterial infections.
https://european-biotechnology.com/wp-content/uploads/2024/04/2019_10_28_bioversys_web.jpg10801920Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-10-29 06:00:002019-10-29 06:00:00BioVersys receives up to €8m from CARB-X
NSCLC: Bemcentinib + anti-PD1 triple PFS
Latest NewsBergen Bio ASA’s Axl kinase blocker bemcentinib in combination with MSD’s pembrolizumab has met the primary endpoint in a Phase II study in patients with non small cell lung cancer (NSCLC).
Transposase makes CAR-T production cheaper
Latest NewsGerman researchers have designed a modified Sleeping Beauty transposase that can be used for non-viral, stable and efficient gene insertions for gene and CAR-T therapies.
New players to step into the AMR field
BackgroundDespite challenging markets new players are entering the field to advance drug development in the fight against antimicrobial resistance.
Oxford BioDynamics: Decorated board member
AppointmentsRenowned immunologist Iain McInnes has been appointed to the Scientific Advisory Boar of Oxford BioDynamics Plc, where he joins Karol Sikora, Jane Mellor and Lucien Peng-Jin Ooi.
Test detects breast cancer in earliest stage
Latest NewsSustainable DNA extraction
Sponsored PublicationsBioEcho develops single-spin and 96-well kits for the isolation of DNA from different starting materials. In contrast to common bind-wash-elute procedures their proprietary EchoLUTION single-step technology avoids the use of inhibitory or harmful process reagents and does not require washing steps.
Sherlock Bioscience and Mologic enter partnership
Latest NewsSynbio specialist Sherlock Biosciences and next-generation lateral flow testing expert Mologic Ltd have joined forces to develop a no-instrument rapid testing platform detecting virtually every infectious pathogen in low resource settings.
Protein protects against liver fibrosis
Latest NewsGerman researchers have shown that a protein protects against the development of liver fibrosis by shutting down inflammatory signalling in liver stellate cells of the liver.
bit bio restarts with new management
Latest NewsCell reprogramming specialist bit bio has expanded its management with renowned experts in the field.
BioVersys receives up to €8m from CARB-X
Latest NewsSwiss biotech company BioVersys AG has received a €8m grant by US-based non-profit organisation CARB-X to develop novel anti-virulence antibiotics to treat severe bacterial infections.